Feature Channels: Infectious Diseases

Filters close
Released: 20-Nov-2024 12:00 PM EST
Expert Available: Severe Case of Monkeypox Confirmed in California
George Washington University

According to the CDC, a severe case of monkeypox has been confirmed in California. This is the first known case of the clade 1 strain in the United States. ...

Released: 20-Nov-2024 11:55 AM EST
Un antibiótico innovador para bacterias resistentes a los fármacos
American Chemical Society (ACS)

Sobre la base de trabajos anteriores, los investigadores de ACS Infectious Diseases han demostrado un posible tratamiento antibacteriano a partir de una darobactina modificada, un compuesto originario de una bacteria. El equipo informa de pruebas de concepto en animales con infecciones causadas por bacterias, entre ellas, E. coli, conocidas por desarrollar farmacorresistencia.

   
Released: 20-Nov-2024 11:00 AM EST
How Protective Antibodies Get in Malaria’s Way
Fred Hutchinson Cancer Center

In work published in Nature, researchers’ structural insights help reveal a weak spot in malaria’s plan of attack which could help guide vaccine design.

15-Nov-2024 8:00 AM EST
An Innovative Antibiotic for Drug-Resistant Bacteria
American Chemical Society (ACS)

Building on previous work, researchers in ACS Infectious Diseases have demonstrated a potential antibacterial treatment from a modified darobactin, a compound originally from a bacterium. The team reports proof-of-concept animal trials on infections caused by bacteria, including E. coli, that are known to develop drug resistance.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 22-Nov-2024 5:00 AM EST Released to reporters: 19-Nov-2024 4:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 22-Nov-2024 5:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 25-Nov-2024 5:00 PM EST Released to reporters: 19-Nov-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Nov-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Nov-2024 12:25 PM EST
La Jolla Institute for Immunology Launches New International Research Partnership with Link Campus University
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) and Link Campus University of Rome, Italy, and have signed a collaborative agreement as part of a strategic program aimed at promoting scientific research and innovation between the United States and Italy.

Newswise: Seemingly “Broken” Genes in Coronaviruses May be Essential for Viral Survival
14-Nov-2024 2:55 PM EST
Seemingly “Broken” Genes in Coronaviruses May be Essential for Viral Survival
University of Utah Health

Researchers have found that some coronavirus genes don’t produce a working protein, but nevertheless appear evolutionarily advantageous. Their work investigating how these mystery genes evolve could help forecast which viral variants might be more dangerous.

Not for public release

This news release is embargoed until 18-Nov-2024 5:00 PM EST Released to reporters: 12-Nov-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 18-Nov-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 1920_1920-vaccine-cedars-sinai.jpg?10000
Released: 18-Nov-2024 11:10 AM EST
Cómo Mantener a los Mayores Fuera del Hospital Durante la Temporada de la Gripe
Cedars-Sinai

La influenza puede ser una enfermedad desagradable de una semana de duración y un inconveniente para muchas personas, pero puede tener consecuencias graves para los adultos mayores.

Newswise: 1920_vaccine-cedars-sinai.jpg?10000
Released: 18-Nov-2024 10:45 AM EST
How to Keep Older Adults Out of the Hospital During Flu Season
Cedars-Sinai

The flu might be a miserable weeklong illness and inconvenience for many people, but it can have serious consequences for older adults.

Newswise: Why the Bird Flu’s Jump to Pigs Is Concerning
Released: 18-Nov-2024 9:15 AM EST
Why the Bird Flu’s Jump to Pigs Is Concerning
Michigan Medicine - University of Michigan

A University of Michigan virologist's take on the current situation

Newswise: Study Challenges Assumptions About How Tuberculosis Bacteria Grow
Released: 15-Nov-2024 2:50 PM EST
Study Challenges Assumptions About How Tuberculosis Bacteria Grow
Tufts University

The rod-shaped tuberculosis (TB) bacterium, which the World Health Organization has once again ranked as the top infectious disease killer globally, is the first single-celled organism ever observed to maintain a consistent growth rate throughout its life cycle. These findings, reported by researchers on November 15 in the journal Nature Microbiology, overturn core beliefs of bacterial cell biology and hint at why the deadly pathogen so readily outmaneuvers our immune system and antibiotics.

   
Newswise: Hackensack Meridian Jersey Shore University and Hackensack University Medical Centers Achieve Excellence in Life Support Care
Released: 15-Nov-2024 9:15 AM EST
Hackensack Meridian Jersey Shore University and Hackensack University Medical Centers Achieve Excellence in Life Support Care
Hackensack Meridian Health

Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center are the only New Jersey hospitals to achieve the Extracorporeal Life Support Organization’s (ELSO) Gold Level Center of Excellence in Life Support Award.

Newswise: Study Uncovers First Evidence of Resistance to Standard Malaria Treatment in African Children with Severe Malaria
Released: 14-Nov-2024 2:45 PM EST
Study Uncovers First Evidence of Resistance to Standard Malaria Treatment in African Children with Severe Malaria
Indiana University

An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives — the primary treatment for malaria — in young children with severe malaria.

Newswise: Optical Biosensor Rapidly Detects Monkeypox Virus
Released: 14-Nov-2024 2:30 PM EST
Optical Biosensor Rapidly Detects Monkeypox Virus
University of California San Diego

Researchers at UC San Diego and their colleagues have developed an optical biosensor that detects the virus that causes mpox. The technology could make diagnosis much faster and cost-effective as the disease continues to spread worldwide.

Released: 14-Nov-2024 7:55 AM EST
New Roles in Infectious Process for Molecule That Inhibits Flu
Ohio State University

Researchers have identified new roles for a protein long known to protect against severe flu infection – among them, raising the minimum number of viral particles needed to cause sickness.

Released: 13-Nov-2024 6:35 PM EST
Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains
Rutgers University-New Brunswick

Rutgers Health study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments.



close
4.09429